Editorial: Microbiota and metabolites in cancer immunotherapy

Front Oncol. 2022 Dec 6:12:1093941. doi: 10.3389/fonc.2022.1093941. eCollection 2022.

Authors

Giandomenico Roviello¹, Martina Catalano¹

Affiliation

¹ Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.

No abstract available

Keywords: cytotoxic T-lymphocyte antigen (CTLA-4); gut microbiota; immune checkpoint inhibitors; immunotherapy; programmed death/ligand-1.

Publication types

Editorial